CYTOO

CYTOO will be at the ASCB Annual Meeting in New Orleans, USA, to present its 2D+ and 3D Cell Culture Platform. This innovative solution opens fresh perspectives for cell based assay development, through more physiologically relevant cellular models.

At MipTec 2013 in Basel, Switzerland, CYTOO will present the 2D+ and 3D+ Cell Culture Platforms, opening fresh perspectives for cell based assay development in drug discovery.

CYTOO, a French biotechnology company providing research and development tools based on cell architecture, welcomes Marc Le Bozec as Chief Executive Officer.

Grenoble, France, 18th March 2013, CYTOO, a life science systems & tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS), is delighted to announce that Olivier Pasquier has joined the team as Chief...

CYTOO, a life science systems & tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS) is proud to announce that CYTOO’s adhesive micropatterns are mentioned in more than 30 publications, covering a wide...

CYTOO will attend the BPS Annual Meeting in Philadelphia to present its innovative Cell Culture Platform, based on adhesive micropatterns. After the launch of the CYTOOplates Motility, the company has the pleasure to sponsor the Motility subgroup.

CYTOO will attend the Society for Laboratory Automation and Screening conference to present the 2D+ Solutions. Kristine Schauer’s Organelle Map figures among the nine 2013 SLAS Innovation Award finalists.

CYTOO’s 2D+ Solutions open fresh perspectives for cell based assay development in drug discovery

CYTOO will offer a significant discount on all CYTOO Motility products at the ASCB 2012 Annual meeting in San Francisco: attendees are invited to visit ASCB Booth #329 for this exclusive offer!

CYTOO will launch the CYTOOplates Motility to study cell migration for screening applications in both oncology and drug discovery at the ASCB 2012 Annual meeting in San Francisco, USA.